The DTC staple, structurally validated, induced the formation of and stabilized a productive α-helical conformation of PMI – a dual-specificity peptide antagonist of MDM2 and MDMX, enabling it to traverse the cell membrane and kill tumor cells by reactivating the p53 pathway. This evidence concerns the gene MDM4 and neoplasm.